Clorox (CLX) Receivables (2009 - 2026)

Clorox's Receivables history runs 18 years deep, the most recent figure standing at $671.0 million for Q1 2026.

• On a quarterly basis, Receivables rose 12.4% year-over-year to $671.0 million in Q1 2026; TTM through Mar 2026 was $671.0 million, a 12.4% increase from a year earlier, with the FY2025 full-year figure at $837.0 million, up 14.03% from the prior year.
• Receivables held at $671.0 million in Q1 2026 per CLX's latest filing, from $671.0 million in the prior quarter.
• Across five years, Receivables topped out at $837.0 million in Q2 2025 and bottomed at $581.0 million in Q3 2023.
• The 5-year median for Receivables is $671.0 million (2025), against an average of $664.6 million.
• Biggest YoY gain for Receivables was 18.15% in 2025; the steepest drop was 11.29% in 2025.
• Year by year, Receivables stood at $600.0 million in 2022, then climbed by 13.17% to $679.0 million in 2023, then declined by 11.19% to $603.0 million in 2024, then advanced by 11.28% to $671.0 million in 2025, then changed by 0.0% to $671.0 million in 2026.
• Per Business Quant, the three latest CLX Receivables figures stand at $671.0 million (Q1 2026), $671.0 million (Q4 2025), and $703.0 million (Q3 2025).